BioSpace News Archive

BioMidwest

Workers’ Compensation Benchmarking Study Releases Annual 2018 Report on Advancing Medical Management

FOCUS GROUP RESEARCH EXAMINES CORE COMPETENCY MOST CRITICAL TO CLAIM OUTCOMES

December 18, 2018
·
4 min read
Business

West Announces Quarterly Dividend and Participation in Upcoming Investor Conference

West Pharmaceutical Services, Inc. today announced that the Company’s Board of Directors has approved a first-quarter 2019 dividend of $0.15 per share. The dividend will be paid on February 6, 2019, to shareholders of record as of January 23, 2019.

December 18, 2018
·
1 min read
Pharm Country

Amphetamine Use, Abuse and Dependence Claim Lines Increased over 3,000 Percent in 10 Years

Anxiety Claim Lines Rose over 200 Percent, FAIR Health Study Shows

December 18, 2018
·
4 min read
Genetown

Epizyme Earns $8 Million Milestone Payment from GlaxoSmithKline for Initiation of Clinical Development for First-in-Class PRMT1 Inhibitor

Epizyme, Inc. today announced it has earned an $8 million milestone payment from GlaxoSmithKline (GSK).

December 18, 2018
·
5 min read
Biotech Beach

AmpliPhi Biosciences Successfully Optimizes Manufacturing Process and Scale Up for AB-SA01 Clinical Development

AmpliPhi’s wholly owned GMP facility now capable of producing material for over 100,000 doses from each drug substance batch of AB-SA01, sufficient to support clinical trial requirements

December 18, 2018
·
5 min read
Lilly announces publication of analyses showing benefit of the addition of Verzenio® (abemaciclib) in multiple subgroups of patients with advanced breast cancer identified as having a more concerning prognosis

Subgroup analyses demonstrate consistent benefit in subgroups of patients with a more concerning prognosis such as those with liver metastases, PR-negative disease, high tumor grade, or shorter treatment-free interval

December 18, 2018
·
21 min read
Policy

Cipher Pharmaceuticals Announces A-101 40% Topical Solution Accepted for Review by Health Canada

Cipher Pharmaceuticals Inc. announced that its New Drug Submission (“NDS”) for A-101 40% topical solution (“A-101 40%") for the treatment of raised seborrheic keratoses (“SKs”) has been accepted for review by Health Canada.

December 18, 2018
·
8 min read
Deals

Bruker Completes the Acquisition of Alicona Imaging GmbH

Bruker Corporation announced that it has completed its previously announced acquisition of Alicona Imaging GmbH, a leading provider of optical-based metrology products in Graz, Austria.

December 18, 2018
·
3 min read
Deals

Cybeats Announces $3M Investment for Cybersecurity and Lifecycle Management for IoT Devices

Cybersecurity protection solution provides software-based microagent for smart buildings, medical devices, and critical infrastructure

December 18, 2018
·
4 min read
Policy

Initiate Government Solutions, LLC Appraised At CMMI Level 3

Initiate Government Solutions, LLC, announced that its IT Health Services Group has been appraised at level 3 of the CMMI Institute’s Capability Maturity Model Integration (CMMI)® for Services.

December 18, 2018
·
2 min read